Owlstone Medical (“Owlstone”), the global leader in Breath Biopsy® for applications in early disease detection and precision medicine, today announced that it has won an award of up to $49.1 million from the Advanced Research…
Owlstone Medical wins up to $49.1 million award from ARPA-H to develop at-home multi-cancer-early detection tests
